Immucell Corp Stock
Your prediction
Immucell Corp Stock
We can see a decrease in the price for Immucell Corp. Compared to yesterday it has lost -€0.150 (-1.530%).
Pros and Cons of Immucell Corp in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
M***** P*******
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Immucell Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Immucell Corp | -1.530% | 1.047% | 11.561% | 73.874% | 89.216% | 94.556% | 13.529% |
| Larimar Therapeutics Inc. | -1.900% | -11.932% | 17.424% | 16.541% | -6.627% | 11.511% | -64.162% |
| Northwest Biotherapeutics Inc. | -1.330% | 0.000% | 2.069% | -35.088% | -28.155% | -68.511% | -86.038% |
| Achieve Life Sciences Inc. | -0.930% | -2.752% | -1.852% | 145.370% | 43.243% | 10.417% | -12.397% |
News
ImmuCell Q1 Earnings Call Highlights
ImmuCell (NASDAQ:ICCC) reported a record first quarter of 2026, with management saying the company’s narrowed focus on its First Defense calf scours prevention portfolio helped drive its first-ever
